Skip to main content
Clinical Trials/JPRN-UMIN000014652
JPRN-UMIN000014652
Completed
未知

A randomized controlled trial for improving QOL(quality-of-life) concerning knee joint in human - A randomized controlled trial for improving QOL(quality-of-life) concerning knee joint in human

CPCC Company Limited0 sites45 target enrollmentJuly 27, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy volunteer
Sponsor
CPCC Company Limited
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 27, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)Patients being treated for rheumatoid arthritis (2\)Subjects who have a weak stomach, be suspected of gastrointestinal disease and/or have diarrhea routinely (3\)Subjects who have previous medical history and/or current medical history of serious diseases (e.g., heart, liver, kidney, pancreas, and/or digestive organ) (4\)Subjects who have hypertension (not less than level 3\) (5\)Subjects who continuously use anti\-inflammatory agent or muscle relaxant (6\)Subjects who continuously use pack and/or topical cream etc. on knee and/or leg region (7\)Subjects who continuously use medicines and/or Chinese herbal medicine, and can't stop using during this trial (8\)Subjects who use functional foods that have mitigation or treatment effect for joint pain (e.g., amino acid, protein, vitamin D, chondroitin, collagen, and/or glucosamine), and can't stop using during this trial (9\)Subjects who have previous medical history of drug and/or food allergy (10\)Subjects with excessive alcohol\-drinking behaviors (11\)Subjects who contract or are under treatment for psychiatric disorder (12\)Subjects who have been enrolled in the other clinical trials within about last 1 month (13\)Subjects who are judged as unsuitable for the trial by the investigator or subinvestigator for other reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials